Application of Quality by Design to Formulation and Processing of Protein Liposomes
Overview
Affiliations
Quality by design (QbD) principles were explored in the current study to gain a comprehensive understanding of the preparation of superoxide dismutase (SOD) containing liposome formulations prepared using freeze-and-thaw unilamellar vesicles (FAT-ULV). Risk analysis and D-optimal statistical design were performed. Of all the variables investigated, lipid concentration, cholesterol mol%, main lipid type and protein concentration were identified as critical parameters affecting SOD encapsulation efficiency, while the main lipid type was the only factor influencing liposome particle size. Using a model generated by the D-optimal design, a series of three-dimensional response spaces for SOD liposome encapsulation efficiency were established. The maximum values observed in the response surfaces indirectly confirmed the existence of a specific SOD-lipid interaction, which took place in the lipid bilayer under the following optimal conditions: (1) appropriate membrane thickness and curvature (DPPC liposomes); and (2) optimal "pocket size" generated by cholesterol content. With respect to storage stability, the prepared SOD liposomes remained stable for at least 6 months in aqueous dispersion state at 4°C. This research highlights the level of understanding that can be accomplished through a well-designed study based on the philosophy of QbD.
Overview of Nanocosmetics with Emphasis on those Incorporating Natural Extracts.
Maghraby Y, Ibrahim A, El-Shabasy R, Azzazy H ACS Omega. 2024; 9(34):36001-36022.
PMID: 39220491 PMC: 11360025. DOI: 10.1021/acsomega.4c00062.
From lab to industrial development of lipid nanocarriers using quality by design approach.
Buya A, Mahlangu P, Witika B Int J Pharm X. 2024; 8:100266.
PMID: 39050378 PMC: 11268122. DOI: 10.1016/j.ijpx.2024.100266.
Dawoud M, Mannaa I, Abdel-Daim A, Sweed N AAPS PharmSciTech. 2023; 24(6):169.
PMID: 37552427 DOI: 10.1208/s12249-023-02609-5.
Quality by Design Approach in Liposomal Formulations: Robust Product Development.
Alshaer W, Nsairat H, Lafi Z, Hourani O, Al-Kadash A, Esawi E Molecules. 2023; 28(1).
PMID: 36615205 PMC: 9822211. DOI: 10.3390/molecules28010010.
Barbalata C, Porfire A, Casian T, Muntean D, Rus I, Tertis M Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297322 PMC: 9611314. DOI: 10.3390/ph15101211.